Molecular characteristics of fluoroquinolone-resistant Escherichia coli isolated from suckling piglets with colibacillosis

被引:4
作者
Seo K. [1 ,2 ]
Do K.-H. [2 ,3 ]
Lee W.-K. [2 ,3 ]
机构
[1] Korea Zoonosis Research Institute, Jeonbuk National University, Iksan
[2] College of Veterinary Medicine, Chungbuk National University, Cheongju
[3] Laboratory of Veterinary Bacteriology and Infectious Diseases, College of Veterinary Medicine, Chungbuk National University, Cheongju
关键词
Antimicrobial resistance; Colibacillosis; Escherichia coli; Fluoroquinolone; Plasmid-mediated quinolone resistance;
D O I
10.1186/s12866-022-02632-9
中图分类号
学科分类号
摘要
Objectives: Colibacillosis is a frequent enteric disease in the pig industry that causes significant economic losses. The objective of this study was to investigate the molecular characteristics of fluoroquinolone (FQ)-resistant E. coli isolates from suckling piglets with colibacillosis. Results: A total of 43 FQ-resistant E. coli isolates were tested in this study and all isolates showed multi-drug resistance (MDR) and mutations in quinolone resistance determining regions (gyrA or parC). Especially, FQ-resistant E. coli isolates with double mutations in both gyrA and parC were shown a high FQs minimum inhibitory concentration (≥ 64 mg/L for ciprofloxacin, ≥ 128 mg/L for enrofloxacin, and ≥ 256 mg/L for norfloxacin). Among 43 FQ-resistant E. coli isolates, 12 (27.9%) were showed plasmid-mediated quinolone resistance (PMQR) positive E. coli. Prevalence of PMQR gene, aac(6’)-Ib-cr, qnrS, and qepA, were identified in 7, 3, and 2 E. coli isolates, respectively. We identified the following in PMQR-positive E. coli isolates: the tetracycline resistance genes tetD (12 isolates, 100.0%), tetE (12 isolates, 100.0%), tetA (11 isolates, 91.7%), and tetB (1 isolate, 8.3%); β-lactamases–encoding blaCMY-2 (10 isolates, 83.3%), blaTEM-1 (7 isolates, 58.3%), blaOXA-1 (7 isolates, 58.3%), blaSHV-1 (3 isolates, 16.7%), and blaAAC-2 (1 isolate, 8.3%); and the chloramphenicol resistance genes (10 isolates, 83.3%); the sulfonamide resistance genes sul1 (9 isolates, 75.0%) and sul2 (10 isolates, 83.3%); the aminoglycoside modifying enzyme gene aac(3)-II (2 isolates, 16.7%). The F4 (7 isolates, 58.3%), LT:STb:EAST1 (5 isolates, 41.7%), and paa (3 isolates, 25.0%) were most common fimbrial antigen, combinations of toxin genes, and non-fimbrial adhesins genes, respectively. All PMQR-positive E. coli carried class I integrons but only 4 isolates carried the gene cassette. The most prevalent plasmid replicon was FIB (9 isolates, 75.0%), followed by FIC, HI1, and N (7 isolates, 58.3%), respectively. Conclusions: Because FQ-resistant E. coli can serve as a reservoir of FQ resistant genetic determinants that can be transferred to pathogenic bacteria in humans or pigs, this represents a public health hazard. © 2022, The Author(s).
引用
收藏
相关论文
共 54 条
[1]  
Luppi A., Swine enteric colibacillosis: diagnosis, therapy and antimicrobial resistance, Porcine Health Manag, 3, (2017)
[2]  
Fairbrother J.M., Gyles CL. Diseases of Swine Chapter: Colibacillosis. 9th ed, Straw BE, pp. 387-395, (2006)
[3]  
Critically Important Antimicrobials for Human Medicine – 5Th Rev. Geneva: World Health Organization, (2017)
[4]  
Hong J., Kim J.M., Jung W.K., Kim S.H., Bae W., Koo H.C., Et al., Prevalence and antibiotic resistance of campylobacter spp. Isolated from chicken meat, pork, and beef in Korea, from 2001 to 2006, J Food Prot, 70, pp. 860-866, (2007)
[5]  
Yoshida H., Bogaki M., Nakamura M., Nakamura S., Quinolone resistance determining region in the DNA gyrase gyrA gene of Escherichia coli, Antimicrob Agents Chemother, 34, pp. 1271-1272, (1990)
[6]  
Heisig P., Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli, Antimicrob Agents Chemother, 40, pp. 879-885, (1996)
[7]  
Tran J.H., Jacoby G.A., Mechanism of plasmid mediated quinolone resistance, PNAS, 99, pp. 5638-5642, (2002)
[8]  
Poirel L., Rodriguez-Martinez J.M., Mammeri H., Liard A., Nordmann P., Origin of plasmid-mediated quinolone resistance determinant QnrA, Antimicrob Agents Chemother, 49, pp. 3523-3525, (2005)
[9]  
Yamane K., Wachino J.I., Suzuki S., Kimura K., Shibata N., Kato H., Et al., New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate, Antimicrob Agents Chemother, 51, pp. 3354-3360, (2007)
[10]  
Park C.H., Robicsek A., Jacoby G.A., Sahm D., Hooper D.C., Prevalence in the United States of aac (6’)-Ib-cr encoding a ciprofloxacin-modifying enzyme, Antimicrob Agents Chemother, 50, pp. 3953-3955, (2006)